Tirzepatide to Slow Biological Aging

NCT07220473 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Aging
LONGEVITY 1

Interventions

DRUG: Zepbound

Sponsor

The University of Texas Medical Branch, Galveston